The major barrier to HIV-1 eradication is a small pool of resting memory CD4 + T cells that carry stably integrated, replication-competent HIV-1 genomes . There is great current interest in developing novel strategies for targeting this reservoir. However, the practical challenges inherent in doing this remain daunting. The purpose of this article is to describe some of these practical challenges in a quantitative way.
The diagnosis is typically made on final pathology since clinical findings and imaging techniques are non-specific. The only curative treatment is surgical resection, either by open or laparoscopic surgery. In our work, we report the case of a giant seminal vesicle cystadenoma in an 80 yearsold patient in whom the huge abdominal cystic mass was suspicious to be related to a malignant process since it presented intimate contact with pelvic structures. Pathological examination after excision of the mass has confirmed the nature of the huge mass as a benign cystadenoma of the seminal vesicle.The seminal vesicles are paired organs that have a posterior location to the bladder and prostate. A seminal vesicle has a capacity for around 4 ml, and has a length of 5-7 cm. The secretions of seminal vesicles make up 80% of seminal fluid . Primary tumors of the seminal vesicles are very rare and could be benign or malignant and Benign tumors, such as cystadenomas are rarer than malignant ones . They are usually present in second and third decades of life. High-resolution trans-rectal ultrasonography (TRUS) guided biopsy can be useful for assisting the diagnosis. CT scan and MRI are more performing techniques to characterize the lesion of the seminal vesicle . Because of the rarity of these tumors, there is no defined treatment for their management.